The Food and Drug Administration’s concerns about continued marketing of noncompliant topical analgesics get an indelible stamp of urgency as more US adults are having tattoos applied, and a higher number still will get one or more.
The FDA on 26 March announced warning letters to six businesses found selling directly to consumers topical formulations containing lidocaine outside the 0
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?